Organisation paid for research Program year 2025 Source: CMS Open Payments

A&A Research Group Inc

Neither a doctor nor a teaching hospital

Research payments

$689,000

7 payments

Through program year 2025, A&A Research Group Inc is reported as receiving $689,000 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$202,703	2
2024	Research	$378,816	3
2023	Research	$107,481	2

Breakdown

Who paid Research payments · program years 2023–2025

Novartis Pharmaceuticals Corporation $689,000 7 payments

Studies the money was for Research payments · program years 2023–2025

A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) $524,074 3 payments
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (Victorion-2 Prevent) $154,599 3 payments
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardiovascular disease $10,327 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.